Cowen Starts Radius Health (RDUS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Canaccord Genuity Starts Radius Health (RDUS) at Buy
July 16, 2014 7:30 AM EDTCanaccord Genuity initiated coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Radius Health click here. For more ratings news on Radius Health click here.
Shares of Radius Health closed at $12.14 yesterday.
... MoreJefferies Starts Radius Health (RDUS) at Buy
July 16, 2014 7:23 AM EDTJefferies initiates coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $17.00.
Analyst Eun K. Yang, Ph.D. said, "Ahead of Ph3 data in 12/14, we view highly likely Ph3 success for abaloparatide-SC in osteoporosis (achieving primary endpoint of... More
Cantor Fitzgerald Starts Radius Health (RDUS) at Buy
July 16, 2014 6:52 AM EDTCantor Fitzgerald initiates coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $20.00.
Analyst Mara Goldstein said, " We like the simplicity of the company's value proposition: a late stage asset with near-term revenue potential, with the potential... More
